These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2965270)

  • 1. [The identification of inhibitors of acantholysis of pemphigus vulgaris].
    Naito K
    Nihon Hifuka Gakkai Zasshi; 1987 Oct; 97(11):1231-8. PubMed ID: 2965270
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmin induces acantholysis in skin organ cultures.
    Hunziker T; Vassalli JD
    Arch Dermatol Res; 1987; 279(5):341-6. PubMed ID: 2957965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinase inhibitors block formation of pemphigus acantholysis in experimental models of neonatal mice and skin explants: effects of synthetic and plasma proteinase inhibitors on pemphigus acantholysis.
    Naito K; Morioka S; Nakajima S; Ogawa H
    J Invest Dermatol; 1989 Jul; 93(1):173-7. PubMed ID: 2526184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis.
    Anhalt GJ; Patel HP; Labib RS; Diaz LA; Proud D
    J Immunol; 1986 Jan; 136(1):113-7. PubMed ID: 3079604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro studies of acantholysis of keratinocytes induced by pemphigus antibody.
    Hashimoto KH; Jensen PJ; Lazarus GS; Morioka S; Singer KH
    Immunol Ser; 1989; 46():277-90. PubMed ID: 2535130
    [No Abstract]   [Full Text] [Related]  

  • 6. Protease inhibitors prevent plasminogen-mediated, but not pemphigus vulgaris-induced, acantholysis in human epidermis.
    Schuh T; Besch R; Braungart E; Flaig MJ; Douwes K; Sander CA; Magdolen V; Probst C; Wosikowski K; Degitz K
    Biol Chem; 2003 Feb; 384(2):311-5. PubMed ID: 12675525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG.
    Morioka S; Lazarus GS; Jensen PJ
    J Invest Dermatol; 1987 Nov; 89(5):474-7. PubMed ID: 3117905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement fixation by pemphigus antibody. IV. Enhanced epidermal cell detachment in the absence of human plasminogen.
    Doubleday CW; Geoghegan WD; Jordon RE
    J Lab Clin Med; 1988 Jan; 111(1):28-34. PubMed ID: 3335823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of plasminogen activator in pemphigus vulgaris.
    Wilkinson JE; Smith CA; Suter MM; Falchek W; Lewis RM
    Am J Pathol; 1989 Mar; 134(3):561-9. PubMed ID: 2466403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis.
    Morioka S; Naito K; Ogawa H
    J Invest Dermatol; 1981 May; 76(5):337-41. PubMed ID: 7014725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of steroid, retinoid, and protease inhibitors on the formation of acantholysis induced in organ culture of skins from patients with benign familial chronic pemphigus.
    Ikeda S; Ogawa H
    J Invest Dermatol; 1991 Oct; 97(4):644-8. PubMed ID: 1940435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of pemphigus. The role of epidermal plasminogen activators in acantholysis.
    Fabbri P; Lotti T; Panconesi E
    Int J Dermatol; 1985 Sep; 24(7):422-5. PubMed ID: 3902681
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo studies of antibody dependent acantholysis.
    Anhalt GJ; Diaz LA
    Immunol Ser; 1989; 46():291-316. PubMed ID: 2518720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor.
    Hashimoto K; Wun TC; Baird J; Lazarus GS; Jensen PJ
    J Invest Dermatol; 1989 Mar; 92(3):310-4. PubMed ID: 2465356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural studies of acantholysis induced in vivo by passive transfer of IgG from endemic pemphigus foliaceus (Fogo Selvagem).
    Futamura S; Martins C; Rivitti EA; Labib RS; Diaz LA; Anhalt GJ
    J Invest Dermatol; 1989 Oct; 93(4):480-5. PubMed ID: 2778350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Origin and nature of acantholytic cells in pemphigus vulgaris].
    Rodin IuA; Shapovalov IuN; Pototskiĭ II; Dolgov AD
    Vestn Dermatol Venerol; 1975 May; (5):17-22. PubMed ID: 49988
    [No Abstract]   [Full Text] [Related]  

  • 17. Human fibroblasts produce inhibitor directed against plasminogen activator when treated with glucocorticoids.
    Crutchley DJ; Conanan LB; Maynard JR
    Ann N Y Acad Sci; 1981; 370():609-16. PubMed ID: 6455956
    [No Abstract]   [Full Text] [Related]  

  • 18. Pemphigus acantholysis in tissue culture: studies on photo-induction.
    Gschnait F; Pehamberger H; Holubar K
    Acta Derm Venereol; 1978; 58(3):237-9. PubMed ID: 78638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The plasminogen activator/plasmin system.
    Vassalli JD; Sappino AP; Belin D
    J Clin Invest; 1991 Oct; 88(4):1067-72. PubMed ID: 1833420
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel explanation for acantholysis in pemphigus vulgaris: the basal cell shrinkage hypothesis.
    Bystryn JC; Grando SA
    J Am Acad Dermatol; 2006 Mar; 54(3):513-6. PubMed ID: 16488306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.